Decreased agonist, but not antagonist, binding to the naturally occurring Thr 92Lys variant of the h5-HT 7(a) receptor

Abstract

In the present study on transfected human embryonic kidney (HEK)293 cells, we aimed at establishing whether expression of the naturally occurring Thr 92Lys variation of the G s-coupled h5-HT 7(a) receptor leads to changes of ligand binding properties, of agonist-evoked cAMP formation and/or of antagonist-mediated blockade of the latter. Binding of [ 3H]5-carboxamidotryptamine ([ 3H]5-CT) to membranes and stimulated [ 3H]cAMP accumulation in whole cells were determined. Saturation binding experiments in membranes of transiently transfected cells expressing either the wild-type or the variant receptor revealed a single binding site in both cases and no difference in B max between both receptor isoforms. In competition binding experiments in membranes of stably transfected cells, the Thr 92Lys variant exhibited a 2.8–11 times lower binding affinity of the ligands 5-hydroxytryptamine (5-HT), 5-CT, 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4yl)-1H-indole (RU24969), (±)-hydroxy-2-(di- n-propylamino)tetralin hydrobromide (8-OH-DPAT) and sumatriptan compared to the wild-type receptor. However, the variant did not differ from the wild-type with respect to the binding properties of the antagonists ( R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)-pyrrolodine-1-sulfonyl)phenol hydrochloride (SB-269970), risperidone, mesulergine and clozapine. In agreement with the decreased binding affinity of 5-HT, 5-CT, RU24969 and 8-OH-DPAT for the variant receptor, these agonists were less potent in stimulating [ 3H]cAMP accumulation in cells stably expressing the Thr 92Lys h5-HT 7(a) receptor. Sumatriptan did not stimulate cAMP accumulation in spite of its affinity for both receptor isoforms pointing to a putative weak antagonistic property of this drug at the h5-HT 7 receptor. SB-269970 and clozapine were equipotent at both the variant and the wild-type receptor in producing a rightward shift of the 5-HT concentration–response curve for its stimulant effect on [ 3H]cAMP accumulation. In view of, e.g., the purported involvement of the 5-HT 7 receptor in the regulation of circadian rhythm, it may be concluded that the decrease in affinity of 5-HT and other 5-HT receptor agonists at the (Thr 92Lys) h5-HT 7 receptor may be associated with changes of sleep physiology and of actions of new 5-HT 7 receptor agonists designed to treat circadian dysregulation.